| Application no. and date | 15169936.0 (espacenet) (Federated) (European Patent Register), 20070614 | | Patent/reg. no. and date | DK/EP 2944306, 20210127 | | Publication date | 20151118 | | Priority no. and date | US 814484 P, 20060616 | | EP pub. no. and date |
EP 2944306 20151118 | | Effective date | | | Applicant/owner | REGENERON PHARMACEUTICALS, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591-6707, US | | Applicant ref. no. | V52124DK00 | | Inventor | DIX, Daniel, 55 Memory Trail
La Grangeville, NY 12540, US,
FURFINE, Eric, 315 Harrington Avenue
Concord, MA 01742, US,
GRAHAM, Kenneth S., 218 Robbout Road
Pleasant Valley, NY 12569, US,
FRYE, Kelly, 3 McVickers Lane
Mendham, New Jersey 07945, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/17 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) , A61M 5/178 (2006.01) , A61P 27/02 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07K 14/47 (2006.01) | | Title | Egnede VEGF-antagonistformuleringer til intravitreal administration | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
